Point-of-Care Testing for Hepatitis C in the Priority Settings of Mental Health, Prisons, and Drug and Alcohol Facilities-the PROMPt Study

被引:4
作者
McCartney, Erin M. [1 ]
Ralton, Lucy [1 ]
Dawe, Joshua [2 ]
Richmond, Jacqui [2 ]
Zobel, Joshua [3 ]
Wigg, Alan [4 ]
Cock, Victoria [5 ]
Tse, Edmund Y. [3 ]
Rees, Tom [6 ]
Shaw, David [1 ]
Ferguson, Catherine [1 ]
机构
[1] Royal Adelaide Hosp, Infect Dis Dept, Port Rd, Adelaide, SA 5000, Australia
[2] Burnet Inst, Dis Eliminat, Melbourne, Vic, Australia
[3] Royal Adelaide Hosp, Gastroenterolgy & Hepatol Dept, Adelaide, SA, Australia
[4] Southern Adelaide Local Hlth Network, Hepatol & Liver Transplantat Med Unit, Adelaide, SA, Australia
[5] SA Health, Drug & Alcohol Serv, Adelaide, SA, Australia
[6] SA Hlth, Communicable Dis Control Branch, Adelaide, SA, Australia
关键词
hepatitis C virus; point-of-care testing; linkage to care; screening; diagnosis; HCV GENOTYPE 1; INJECT DRUGS; WHOLE-BLOOD; VIRUS; PREVALENCE; INFECTION; THERAPY; PEOPLE;
D O I
10.1093/cid/ciae155
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background A barrier to hepatitis C virus (HCV) cure is conventional testing. The aim of this study was to evaluate the effect of HCV antibody and RNA point-of-care testing (POCT) on testing rates, linkage to care, treatment, and acceptability of testing in 3 priority settings in Australia.Methods Participants were enrolled in an interventional cohort study at a reception prison, inpatient mental health service, and inpatient alcohol and other drug unit, between October 2020 and December 2021. HCV POCT was performed using SD Bioline HCV antibody fingerstick test and a reflexive Xpert HCV Viral Load Fingerstick test using capillary blood samples. A retrospective audit of HCV testing and treatment data was performed at each site for the preceding 12-month period to generate a historical control.Results A total of 1549 participants received a HCV antibody test with 17% (264 of 1549) receiving a positive result, of whom 21% (55 of 264) tested HCV RNA positive. Across all settings the rate of testing per year significantly increased between the historical controls and the study intervention period by 2.57 fold (rate ratio, 2.57 [95% confidence interval, 2.32-2.85]) for HCV antibody testing and 1.62 (rate ratio, 1.62 [95% confidence interval, 1.31-2.01]) for RNA testing. Treatment uptake was higher during the POCT intervention (86% [47 of 55]; P = .01) compared to the historical controls (61% [27 of 44]).Conclusions This study demonstrated across 3 settings that the use of HCV antibody and RNA POCT increased testing rates, treatment uptake, and linkage to care. The testing model was highly acceptable for most participants.Clinical Trials Registration ACTRN-12621001578897 A barrier to hepatitis C virus (HCV) cure is conventional testing. The PROMPt study demonstrated that HCV antibody and RNA point-of-care testing increased testing rates, linkage to care, and treatment uptake in 3 priority settings in Australia.
引用
收藏
页码:965 / 973
页数:9
相关论文
共 43 条
[1]   Assessing hepatitis C spontaneous clearance and understanding associated factorsA systematic review and meta-analysis [J].
Aisyah, D. N. ;
Shallcross, L. ;
Hully, A. J. ;
O'Brien, A. ;
Hayward, A. .
JOURNAL OF VIRAL HEPATITIS, 2018, 25 (06) :680-698
[2]  
[Anonymous], 2022, AUSTR RECOMMENDATION
[3]  
[Anonymous], 2021, Global health sector strategy on sexually transmitted infections 2016-2021: implementation framework for the African Region: report by the Secretariat. Disponivel em "lt
[4]   Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia [J].
Bajis, Sahar ;
Maher, Lisa ;
Treloar, Carla ;
Hajarizadeh, Behzad ;
Lamoury, Francois M. J. ;
Mowat, Yasmin ;
SchulZ, Marcel ;
Marshall, Alison D. ;
Cunningham, Evan B. ;
Cock, Victoria ;
Ezard, Nadine ;
Gorton, Carla ;
Hayllar, Jeremy ;
Smith, Julie ;
Whelan, Michelle ;
Martinello, Marianne ;
Applegate, Tanya L. ;
Dore, Gregory J. ;
Grebely, Jason .
INTERNATIONAL JOURNAL OF DRUG POLICY, 2018, 61 :23-30
[5]   Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study [J].
Blach, Sarah ;
Terrault, Norah A. ;
Tacke, Frank ;
Gamkrelidze, Ivane ;
Craxi, Antonio ;
Tanaka, Junko ;
Waked, Imam ;
Dore, Gregory J. ;
Abbas, Zaigham ;
Abdallah, Ayat R. ;
Abdulla, Maheeba ;
Aghemo, Alessio ;
Aho, Inka ;
Akarca, Ulus S. ;
Alalwan, Abduljaleel M. ;
Blome, Marianne Alanko ;
Al-Busafi, Said A. ;
Aleman, Soo ;
Alghamdi, Abdullah S. ;
Al-Hamoudi, Waleed K. ;
Aljumah, Abdulrahman A. ;
Al-Naamani, Khalid ;
Al Serkal, Yousif M. ;
Altraif, Ibrahim H. ;
Anand, Anil C. ;
Anderson, Motswedi ;
Andersson, Monique, I ;
Athanasakis, Kostas ;
Baatarkhuu, Oidov ;
Bakieva, Shokhista R. ;
Ben-Ari, Ziv ;
Bessone, Fernando ;
Biondi, Mia J. ;
Bizri, Abdul Rahman N. ;
Mello, Carlos E. Brandaoo ;
Brigida, Krestina ;
Brown, Kimberly A. ;
Brown, Robert S., Jr. ;
Bruggmann, Philip ;
Brunetto, Maurizia R. ;
Busschots, Dana ;
Buti, Maria ;
Butsashvili, Maia ;
Cabezas, Joaquin ;
Chae, Chungman ;
Ivanova, Viktorija Chaloska ;
Chan, Henry Lik Yuen ;
Cheinquer, Hugo ;
Cheng, Kent Jason ;
Cheon, Myeong Eun .
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (05) :396-415
[6]   Diagnostic Accuracy of Assays Using Point-of-Care Testing or Dried Blood Spot Samples for the Determination of Hepatitis C Virus RNA: A Systematic Review [J].
Catlett, Beth ;
Hajarizadeh, Behzad ;
Cunningham, Evan ;
Wolfson-Stofko, Brett ;
Wheeler, Alice ;
Khandaker-Hussain, Benazir ;
Feld, Jordan J. ;
Martro, Elisa ;
Chevaliez, Stephane ;
Pawlotsky, Jean Michel ;
Bharat, Chrianna ;
Cunningham, Philip H. ;
Dore, Gregory J. ;
Applegate, Tanya ;
Grebely, Jason .
JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (06) :1005-1021
[7]   Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis [J].
Cunningham, Evan B. ;
Wheeler, Alice ;
Hajarizadeh, Behzad ;
French, Clare E. ;
Roche, Rachel ;
Marshall, Alison D. ;
Fontaine, Guillaume ;
Conway, Anna ;
Valencia, Braulio M. ;
Bajis, Sahar ;
Presseau, Justin ;
Ward, John W. ;
Degenhardt, Louisa ;
Dore, Gregory J. ;
Hickman, Matthew ;
Vickerman, Peter ;
Grebely, Jason .
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (05) :426-445
[8]   Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review [J].
Degenhardt, Louisa ;
Webb, Paige ;
Colledge-Frisby, Samantha ;
Ireland, Jeremy ;
Wheeler, Alice ;
Ottaviano, Sophie ;
Willing, Alex ;
Kairouz, Abe ;
Cunningham, Evan B. ;
Hajarizadeh, Behzad ;
Leung, Janni ;
Tran, Lucy ;
Price, Olivia ;
Peacock, Amy ;
Vickerman, Peter ;
Farrell, Michael ;
Dore, Gregory J. ;
Hickman, Matthew ;
Grebely, Jason .
LANCET GLOBAL HEALTH, 2023, 11 (05) :E659-E672
[9]   Outcomes of the CT2 study: A 'one-stop-shop' for community-based hepatitis C testing and treatment in Yangon, Myanmar [J].
Draper, Bridget Louise ;
Htay, Hla ;
Pedrana, Alisa ;
Yee, Win Lei ;
Howell, Jessica ;
Kyi, Khin Pyone ;
Naing, Win ;
Aung, Khin Sanda ;
Markby, Jessica ;
Easterbrook, Philippa ;
Bowring, Anna ;
Aung, Win ;
Sein, Yi Yi ;
Nwe, Nwe ;
Myint, Kyi Thar ;
Shilton, Sonjelle ;
Hellard, Margaret .
LIVER INTERNATIONAL, 2021, 41 (11) :2578-2589
[10]   Response guided therapy for reducing duration of direct acting antivirals in chronic hepatitis C infected patients: a Pilot study [J].
Etzion, Ohad ;
Dahari, Harel ;
Yardeni, David ;
Issachar, Assaf ;
Nevo-Shor, Anat ;
Cohen-Naftaly, Michal ;
Ashur, Yaffa ;
Uprichard, Susan L. ;
Arbib, Orly Sneh ;
Munteanu, Daniela ;
Braun, Marius ;
Cotler, Scott J. ;
Abufreha, Naim ;
Keren-Naus, Ayelet ;
Shemer-Avni, Yonat ;
Mor, Orna ;
Murad, Jayanah ;
Novack, Victor ;
Shlomai, Amir .
SCIENTIFIC REPORTS, 2020, 10 (01)